Close

Drug Research

Alnylam and Ascletis collaborate to develop ALN-VSP for liver...

Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have entered into a partnership to develop a systemically delivered RNAi therapeutic, ALN-VSP, for the treatment of liver cancers...

Takeda signs Omontys injection supply contract with Fresenius

Takeda Pharmaceuticals America (TPA) has signed a contract to supply Omontys injection to Fresenius Medical Care North America and certain of its affiliates. ...

Boehringer, Eli Lilly to launch diabetes drug in India

Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults,...

BioBlocks, Full Spectrum to develop new small molecule therapeutics

Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule Therapeutics for protein-protein interactions. As part...

Mylan receives FDA approval for generic Lipitor ANDA

Mylan Laboratories, formerly Matrix Laboratories, has gained final FDA approval for its abbreviated new drug application (ANDA) of Atorvastatin Calcium Tablets of strengths 10mg,...

Cellectricon introduces Cellaxess discovery platform

Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells. Developed in collaboration...

Aegis wins US patent for octreotide formulations

Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read